Surrozen SRZN
NASDAQ SRZN
$22.76 +0.22 (+0.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Surrozen (SRZN) Other Working Capital Changes (2020 - 2026)

Surrozen (SRZN) posted quarterly Other Working Capital Changes of $139000.0 for Q1 2026, up 917.65% year-over-year from $13659.0 in Q1 2025, and up 131.38% quarter-over-quarter from -$443000.0 in Q4 2025.

Analysis

Surrozen (SRZN) Other Working Capital Changes (2020 - 2026) Analysis & Trends

Surrozen's Other Working Capital Changes history runs 7 years deep, the most recent figure standing at $139000.0 for Q1 2026.

  • In Q1 2026, Other Working Capital Changes rose 917.65% year-over-year to $139000.0; the TTM figure through Mar 2026 stood at -$1.7 million (down 431.49% YoY), while the FY2025 annual figure was -$1.8 million, down 2477.46% from the prior year.
  • Other Working Capital Changes for Q1 2026 stood at $139000.0, up from -$443000.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $2.2 million in Q3 2022, with the low at -$1.1 million in Q2 2023.
  • The 5-year median for Other Working Capital Changes is -$274000.0 (2022), against an average of -$116235.3.
  • The sharpest annual moves came in 2024 and 2026: Other Working Capital Changes plunged 29750.0% in 2024, then jumped 917.65% in 2026.
  • Surrozen's Other Working Capital Changes stood at -$2.6 million in 2022, then jumped by 161.07% to $1.6 million in 2023, then sank by 101.27% to -$20000.0 in 2024, then plunged by 2115.0% to -$443000.0 in 2025, then jumped by 131.38% to $139000.0 in 2026.
  • Business Quant data shows SRZN's Other Working Capital Changes at $139000.0 in Q1 2026, -$443000.0 in Q4 2025, and -$1.4 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Surrozen 263.35 Mn 263.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -462,000.00
Jun 30, 2026 -462,000.00
Mar 31, 2026 139,000.00
Mar 31, 2026 139,000.00
Dec 31, 2025 -443,000.00
Dec 31, 2025 -443,000.00
Sep 30, 2025 -432,000.00
Sep 30, 2025 -432,000.00
Jun 30, 2025 -454,000.00
Jun 30, 2025 -454,000.00
Mar 31, 2025 -501,000.00
Mar 31, 2025 -501,000.00
Dec 31, 2024 -492,000.00
Dec 31, 2024 -492,000.00
Sep 30, 2024 -639,000.00
Sep 30, 2024 -639,000.00
Jun 30, 2024 -620,000.00
Jun 30, 2024 -620,000.00
Mar 31, 2024 -593,000.00
Mar 31, 2024 -593,000.00